InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,426.05
(
-0.14%
)
US TECH 100
19,146.00
(
0.40%
)
Dow Jones
38,527.64
(
-0.31%
)
Brent Oil
82.68
(
0.85%
)
Bitcoin
65,429.16
(
-1.99%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bb56

Send PM Follow Ignore
Followers 0
Posts 9
Boards Moderated 0
Alias Born 06/30/2010

bb56

Re: None

Monday, 11/07/2011 1:56:03 PM

Monday, November 07, 2011 1:56:03 PM

Post# of 80490
ARIA
theflyonthewall.com: Ariad PACE results positive, says Oppenheimer
Oppenheimer said Ariad's PACE results for ponatinib in 3rd/4th-line CML had compelling MCyR rates and were consistent with Ph 1 results at 3 months. The firm believes the data supports ponatinib approval. Shares are Outperform rated with a $17 price target. :theflyonthewall.com

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up